Close Menu
June 23, 2020
Sponsored by

Building Global Startups: An Expert Panel on Entrepreneurship in Genomics


Global Head, Illumina Accelerator

Co-founder & CEO, Biome Makers

Co-founder & CEO, Juno Bio

CEO, BioAmp

Co-Founder and Chief Operating Officer, 4baseCare

The decreasing cost of genomic technologies has democratized their use for many biotech and clinical breakthrough applications. Entrepreneurs are playing a key role in advancing these applications by translating scientific breakthroughs and ideas into commercially viable businesses that transcend borders.

Join the Illumina Accelerator and four global genomics startups in the biotech, clinical, and agricultural industries to discuss key trends in entrepreneurship; how to build a genomics startup from ideation to commercialization; how to access capital; and how to navigate and find opportunity in the current challenging climate.

Sponsored by

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.